When the indication is reported as Cellular therapy (non-HCT) for the patient’s first event, or a post-HCT cellular therapy is reported on an HCT follow-up form, the Cellular Therapy Pre-CTED Form 4000 will come due. Once completed and the data is processed, FormsNet3℠ will add additional forms based on whether the product was genetically modified and if the infusion was post-HCT.
The following sub-sections are available for Cellular Therapy:
- Cell Therapy Training Resources
- CIBMTR Guidance Document for Reporting Autologous Cellular Therapies
- Cell Therapy Reporting Preferences
- How forms come due
- Cell therapy, stand-alone (no HCT forms)
- Co-infusion (with HCT)
- Post-HCT Cellular Therapy (not genetically modified)
- Combined follow up scenarios (HCT + CT (genetically modified))
- HCT -> CT
- CT -> HCT
- 3+ events
- Cell Therapy Studies
- Common questions (to reduce the number of tickets)/Best practices
Last modified:
Sep 23, 2022